Citigroup Issues Positive Forecast for Healthcare Realty Trust (NYSE:HR) Stock Price

Healthcare Realty Trust (NYSE:HR - Get Free Report) had its price target raised by research analysts at Citigroup from $19.00 to $21.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a "neutral" rating on the real estate investment trust's stock. Citigroup's price objective suggests a potential upside of 4.92% from the stock's current price.

A number of other analysts also recently issued reports on the stock. Wall Street Zen upgraded shares of Healthcare Realty Trust from a "sell" rating to a "hold" rating in a report on Saturday, January 31st. Weiss Ratings lowered shares of Healthcare Realty Trust from a "hold (c)" rating to a "sell (d+)" rating in a research note on Monday. UBS Group started coverage on shares of Healthcare Realty Trust in a report on Monday, April 20th. They issued a "neutral" rating and a $18.00 price target on the stock. Finally, Cantor Fitzgerald upped their price objective on Healthcare Realty Trust from $21.00 to $22.00 and gave the company an "overweight" rating in a research note on Monday. Three analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Healthcare Realty Trust has a consensus rating of "Hold" and a consensus price target of $19.50.

Healthcare Realty Trust Price Performance

Shares of NYSE HR traded down $0.22 during midday trading on Thursday, reaching $20.02. The company's stock had a trading volume of 4,602,763 shares, compared to its average volume of 3,819,662. Healthcare Realty Trust has a 12-month low of $14.09 and a 12-month high of $20.46. The firm has a 50 day moving average price of $18.07 and a 200-day moving average price of $17.72. The stock has a market capitalization of $6.98 billion, a P/E ratio of -34.51 and a beta of 0.97.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The real estate investment trust reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.39 by $0.02. Healthcare Realty Trust had a negative return on equity of 4.29% and a negative net margin of 17.34%.The business had revenue of $275.28 million for the quarter, compared to analyst estimates of $283.01 million. During the same period last year, the company posted $0.39 earnings per share. Healthcare Realty Trust's quarterly revenue was down 7.7% compared to the same quarter last year. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. On average, equities analysts predict that Healthcare Realty Trust will post 1.61 EPS for the current year.

Insider Buying and Selling

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian acquired 10,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Friday, March 6th. The stock was acquired at an average cost of $18.09 per share, for a total transaction of $180,900.00. Following the purchase, the director owned 85,520 shares of the company's stock, valued at approximately $1,547,056.80. This represents a 13.24% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.56% of the company's stock.

Institutional Investors Weigh In On Healthcare Realty Trust

Several institutional investors have recently made changes to their positions in the stock. Fifth Third Wealth Advisors LLC grew its position in shares of Healthcare Realty Trust by 4.8% in the first quarter. Fifth Third Wealth Advisors LLC now owns 12,580 shares of the real estate investment trust's stock valued at $214,000 after purchasing an additional 579 shares in the last quarter. US Bancorp DE lifted its holdings in Healthcare Realty Trust by 5.8% during the 3rd quarter. US Bancorp DE now owns 10,959 shares of the real estate investment trust's stock worth $198,000 after purchasing an additional 602 shares in the last quarter. Consolidated Portfolio Review Corp boosted its stake in Healthcare Realty Trust by 1.2% in the 3rd quarter. Consolidated Portfolio Review Corp now owns 55,786 shares of the real estate investment trust's stock worth $1,006,000 after purchasing an additional 637 shares during the period. Linden Thomas Advisory Services LLC boosted its stake in Healthcare Realty Trust by 2.7% in the 3rd quarter. Linden Thomas Advisory Services LLC now owns 31,445 shares of the real estate investment trust's stock worth $567,000 after purchasing an additional 826 shares during the period. Finally, State of Michigan Retirement System grew its holdings in Healthcare Realty Trust by 1.1% during the 1st quarter. State of Michigan Retirement System now owns 83,953 shares of the real estate investment trust's stock valued at $1,426,000 after buying an additional 900 shares in the last quarter.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust NYSE: HR is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company's portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company's properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.